Strategy | Financing Transactions Private Placement / Financing Transactions Freenome: The company raised $254 million of venture funding in a deal led by Roche Venture Fund on February 15, 2024, putting the company’s pre-money valuation at $1.95 billion. Bain...
Strategy | Financing Transactions Private Placement / Financing Transactions Neurona Therapeutics: The company raised $120 million of Series E venture funding in a deal led by Viking Global Investors and Cormorant Asset Management on February 8, 2024, putting the...
Strategy | Financing Transactions Private Placement / Financing Transactions Cellanome: The company raised $150 million of Series B venture funding from Premji Invest (US) and undisclosed investors on January 29, 2024, putting the company’s pre-money valuation...
Strategy | Financing Transactions Private Placement / Financing Transactions Synnovation Therapeutics: The company raised $102 million of Series A venture funding in a deal led by Third Rock Ventures on January 24, 2024, putting the company’s pre-money valuation...
Strategy | Financing Transactions Private Placement / Financing Transactions ClevelandDx: The company raised $75 million through a combination of debt, Series E1 and Series E2 venture funding in a deal led by Novo Holdings on January 17, 2024, putting the...
2023 in 300+ Slides – Click on Strategy below Private Placement / Financing Transactions LB Pharmaceuticals: The company raised $110.7 million of venture funding from Pontifax Venture Capital and other undisclosed investors on January 10, 2024. The company is an...
